Cargando…
Plasma t-PA and PAI-1 Antigen Concentrations in Non-Insulin Dependent Diabetic Patients: Effects of Treatment Modality on Fibrinolysis
Basal plasma tissue type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) antigen levels were studied in 49 non-insulin dependent diabetic patients (23 men, 26 women: ages 51.3±14.9 years) and 16 age matched non-diabetic subjects (9 men, 7 women: ages 49.8±12.2 years)...
Autores principales: | Cho, Yong W., Yang, Dong H., Oh, Do Y., Baick, Seung H., Kim, Sun K., Kim, Sun J., Hong, Sae Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532107/ https://www.ncbi.nlm.nih.gov/pubmed/1306076 http://dx.doi.org/10.3904/kjim.1992.7.2.81 |
Ejemplares similares
-
Interacting hepatic PAI-1/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity
por: Zheng, Ze, et al.
Publicado: (2020) -
The Association of the Metabolic Syndrome with PAI-1 and t-PA Levels
por: Coffey, Christopher S., et al.
Publicado: (2011) -
Expression of uPA, tPA, and PAI-1 in Calcified Aortic Valves
por: Kochtebane, Najlah, et al.
Publicado: (2014) -
A Common Calibrator Does Not Secure Harmonisation of Commercial t-PA and PAI-1 Antigen Measurements
por: de Maat, Moniek P.M., et al.
Publicado: (2001) -
Combination of ultrasound and rtPA enhances fibrinolysis in an In Vitro clot system
por: Masomi-Bornwasser, Julia, et al.
Publicado: (2017)